Remdesivir Stopped Kidney Function in COVID Patients – So Why Did FDA Approve It for Kidney Patients?
Remdesivir may be the most despised drug in American history, earning the nickname “Run, Death Is Near” for its lethal record during COVID-19.
Experts claimed that it would stop COVID-19; instead, it stopped kidney function, then blasted the liver and other organs. Now this reviled destroyer of kidneys has been approved by the U.S. Food and Drug Administration (FDA) for COVID-19 treatment of kidney patients.
Does anybody else feel as if the FDA is shoving its power in our faces and laughing at us?
I’ve been joining online support groups for people who lost loved ones to the Remdesivir Protocol — a nightmarish sequence in which a patient is isolated in the hospital, bullied into taking remdesivir, ventilated and then sedated to death.
Thousands of Americans were killed this way, possibly hundreds of thousands.
These support groups are a deeply somber business. Grieving faces fill the screen of people who lost a parent, spouse, sibling or child. Some speak with icy anger; some choke back sobs as they tell of the deadly abuse inflicted on their loved ones, shattering their families forever.
I asked them what they thought of the FDA’s decision to approve remdesivir for people with severe renal impairment, including dialysis. “Morally, how can you do that?” Joyce Wilson said.
It’s a death sentence. They didn’t care if people had kidney issues or not. My husband went into the hospital in kidney distress. They exacerbated it with Remdesivir. Then they ventilated him, and he died.”
Read more at childrenshealthdefense.org
